Late Thrombectomy in Clinical Practice : Retrospective Application of DAWN/DEFUSE3 Criteria within the German Stroke Registry.
Moriz HerzbergKorbinian ScherlingRobert StahlSteffen TiedtFrank A WollenweberClemens KüpperKatharina FeilRobert ForbrigMaximilian PatzigLars KellertWolfgang G KunzPaul ReidlerHanna ZimmermannThomas LiebigMarianne DieterichFranziska Dornnull nullPublished in: Clinical neuroradiology (2021)
In clinical practice, the high number of patients with a good clinical outcome after endovascular therapy ≥ 6-24 h as in DAWN/DEFUSE3 could not be achieved. Similar outcomes are seen in patients selected for EVT ≥ 6 h based on factors other than CTP. Patients triaged without CTP showed trends for shorter arrival to reperfusion times and higher rates of independence.
Keyphrases
- end stage renal disease
- clinical practice
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- heart failure
- cross sectional
- type diabetes
- acute myocardial infarction
- stem cells
- metabolic syndrome
- acute ischemic stroke
- skeletal muscle
- insulin resistance
- left ventricular
- weight loss
- brain injury
- blood brain barrier
- subarachnoid hemorrhage
- smoking cessation